IPO registrations (S-1, F-1) · Registrants
ROCKWELL MEDICAL, INC.
- SEC CIK
- 1041024 · filings on EDGAR ↗
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC (1997–2012)
- Registration
- Form S-1, first filed 2022-06-22; 1 initial registration, 0 amendments
- Outcome
- Declared effective 2022-07-05
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 30142 WIXOM ROAD, Wixom, MI 48393
- EIN
- 38-3317208
- Ticker
- RMTI (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ROCKWELL MEDICAL, INC. on the corporate pages
Offering terms
- Shares offered
- 11,168,887
- Listing
- Nasdaq under the symbol RMTI
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ROCKWELL MEDICAL, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Rockwell Medical, Inc. Fuzzy (name and state)
- Business registration: ROCKWELL MEDICAL, INC. Fuzzy (name and state)
- Business registration: ROCKWELL MEDICAL, INC. Fuzzy (name and state)
- Business registration: ROCKWELL MEDICAL, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ROCKWELL MEDICAL INC. EXACT (EIN (EXACT))
- Federal award recipient: ROCKWELL MEDICAL, INC Fuzzy (name and state)
- Form D issuer: ROCKWELL MEDICAL, INC. EXACT (CIK (EXACT))
- SEC filer: ROCKWELL MEDICAL, INC. EXACT (CIK (EXACT))
- Person page: Russell H Ellison Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-06-22 | S-1 | S-1 (registration) | ROCKWELL MEDICAL, INC. | 0001104659-22-073500 ↗ |
| 2022-07-05 | EFFECT | EFFECT (declared effective) | ROCKWELL MEDICAL, INC. | 9999999995-22-001967 ↗ |
| 2022-07-22 | EFFECT | EFFECT (declared effective) | ROCKWELL MEDICAL, INC. | 9999999995-22-002146 ↗ |
| 2023-08-22 | EFFECT | EFFECT (declared effective) | ROCKWELL MEDICAL, INC. | 9999999995-23-002471 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-22 | S-1 | registration statement | 11,168,887 | - | Nasdaq RMTI | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bagley Patrick J | Director | 17 | 2006–2018 | ||
| HOLT KENNETH L | Director | 39 | 2006–2017 | ||
| CHIOINI ROBERT L | Director,Officer; Director,Officer,TenPercentOwner | Chairman, President and CEO | 44 | 2007–2017 | |
| BOYD RONALD D | Director | 31 | 2007–2018 | ||
| KLEMA THOMAS E | Officer | Vice President, CFO | 30 | 2007–2017 | |
| Yocum Richard C | Officer | VP - Clin. Dev. & Med. Affairs | 3 | 2009–2010 | |
| Gupta Ajay | Officer | Chief Scientific Officer; Sr. VP & Chief Scientific Off. | 22 | 2009–2020 | |
| HAGELSTEIN DAVID A | TenPercentOwner | 47 | 2009–2013 | ||
| Kausz Annamaria T | Officer | VP of Drug Development | 2 | 2011 | |
| Pratt Raymond Dennis | Officer | Chief Development Officer; Chief Medical Officer; VP of Drug Development | 15 | 2012–2021 | |
| Smith Robin L | Director | 5 | 2016–2019 | ||
| Alexander Coleman Ravich 1991 Irrevocable Trust | Other | 2 | 2017 | ||
| Alyssa Danielle Ravich 1991 Irrevocable Trust | Other | 2 | 2017 | ||
| Curfman Matthew J. | Other; TenPercentOwnerOther | 16 | 2017–2020 | ||
| Norman J. Ravich Irrevocable Trust | Other | 2 | 2017 | ||
| Norman & Sally Ravich Family Trust | Other | 2 | 2017 | ||
| RAVICH MARK H | Director; Other | 14 | 2017–2025 | ||
| RBI PI Manager, LLC | Other; TenPercentOwnerOther | 15 | 2017–2020 | ||
| RBI Private Investment I, LLC | Other | 15 | 2017–2020 | ||
| Richmond Brothers 401(k) Profit Sharing Plan | Other | 15 | 2017–2020 | ||
| Richmond Brothers, Inc. | Other; TenPercentOwnerOther | 16 | 2017–2020 | ||
| Richmond David S. | TenPercentOwnerOther | 16 | 2017–2020 | ||
| RBI Private Investment II, LLC | Other | 15 | 2017–2020 | ||
| COOPER JOHN G | Director | 12 | 2017–2026 | ||
| COLLERAN LISA N | Director | 3 | 2018–2019 | ||
| Wolin Benjamin | Director | 3 | 2018–2019 | ||
| Paul Stuart M | Director,Officer | Chief Executive Officer | 4 | 2018–2019 | |
| Kull David | Officer | Principal Accounting Officer | 4 | 2018–2019 | |
| RBI OPPORTUNITIES FUND, LLC | Other | 11 | 2018–2020 | ||
| Smith Angus W. | Officer | Chief Financial Officer | 4 | 2018–2019 | |
| RBI OPPORTUNITIES FUND II, LLC | Other | 10 | 2019–2020 | ||
| McGarry Paul E | Officer | Principal Accounting Officer; SVP, Finance and CAO; VP, Finance | 6 | 2019–2023 | |
| MCLAUGHLIN JOHN PETER | Director | 5 | 2019–2021 | ||
| Hoffman Marc L | Officer | Chief Medical Officer | 5 | 2019–2023 | |
| ELLISON RUSSELL H | Director; Director,Officer | See Remarks | 5 | 2020–2021 | person page Fuzzy |
| Radie Robert S | Director | 9 | 2020–2026 | ||
| Nissenson Allen | Director | 9 | 2020–2026 | ||
| SKIBSTED RUSSELL | Officer | See Remarks | 3 | 2020–2022 | |
| Smiley Andrea Heslin | Director | 7 | 2020–2025 | ||
| TIMMINS MEGAN C. | Officer | EVP, CLO and Secretary; EVP, CLO & Secretary; See Remarks; SVP, General Counsel | 11 | 2021–2026 | |
| Strobeck Mark | Director,Officer | President and CEO | 16 | 2022–2026 | |
| Lau Joan | Director | 7 | 2023–2026 | ||
| Neri Jesse | Officer | SVP and CFO; SVP, FINANCE; SVP, FINANCE AND CFO | 13 | 2023–2026 | |
| Chole Timothy | Officer | SVP and CCO; SVP, Chief Commercial Officer; SVP, CHIEF COMMERCIAL OFFICER | 12 | 2024–2026 | |
| Irrevocable Larson Family Investment Trust | TenPercentOwner | 2 | 2024–2025 | ||
| Hunter Heather | Officer | Chief Operating Officer; SVP, Chief Operating Officer | 5 | 2025–2026 | |
| Dawson Joseph H | Director | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-10-30 | ROCKWELL MEDICAL, INC. | Pharmaceuticals | $22,000,000 | $22,000,000 | 1 | 1 |
| 2014-10-15 | ROCKWELL MEDICAL, INC. | Other Health Care | $15,000,000 | $15,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Rockwell Medical, Inc. | MI | State business registries | name and state |
| Business registration | ROCKWELL MEDICAL, INC. | MI | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ROCKWELL MEDICAL, INC. | MI | State business registries | name and state |
| Business registration | ROCKWELL MEDICAL, INC. | MI | State business registries | name and state |
| Business registration | ROCKWELL MEDICAL, INC. | MI | State business registries | name and state |
| Federal award recipient | ROCKWELL MEDICAL, INC | MI | Federal spending (USAspending) | name and state |
| Form D issuer | ROCKWELL MEDICAL, INC. | MI | Form D private offerings | CIK (EXACT) |
| Paying company | Rockwell Medical, Inc. | MI | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Rockwell Medical, Inc. | MI | Patents (USPTO) | name and state |
| SEC filer | ROCKWELL MEDICAL, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | ROCKWELL MEDICAL, INC. | MI | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ROCKWELL MEDICAL INC. | EIN (EXACT) | ||
| Person page | Russell H Ellison | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MI first:
- ESPERION THERAPEUTICS INC/MI MI
- QUATRX PHARMACEUTICALS Co MI
- Esperion Therapeutics, Inc. MI
- One World Products, Inc. MI
- Zomedica Corp. MI
- Cirius Therapeutics, Inc. MI
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
- Biofrontera AG 2M
In other datasets, the same topic (Health) in MI:
- Nonprofit: 60-MILE MEN (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health